Pre-Open Stock Movers 3/7: (SKUL) (BIG) (GTAT) Higher; (NVTL) (ALSK) (VNEM) Lower (more...)

March 7, 2014 9:16 AM EST Send to a Friend
Get Alerts SKUL Hot Sheet
Trade SKUL Now!
Join SI Premium – FREE
Skullcandy, Inc. (NASDAQ: SKUL) 25% HIGHER; reported Q4 EPS of $0.13, $0.04 better than the analyst estimate of $0.09. Revenue for the quarter came in at $72.2 million versus the consensus estimate of $71.88 million. Skullcandy, Inc. sees Q1 2014 of ($0.16)-($0.18), versus the consensus of ($0.17). Skullcandy, Inc. sees FY2014 EPS of $0.10-$0.14, versus the consensus of $0.10. Upgraded at Northland Capital Markets and DA Davidson.

Novatel Wireless, Inc. (NASDAQ: NVTL) 22.8% LOWER; reported Q4 EPS of ($0.16), $0.08 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $65.3 million versus the consensus estimate of $73.89 million. The company also guided Q1 lower. Novatel Wireless, Inc. sees Q1 2014 EPS of ($0.22)-($0.15), versus the consensus of ($0.07). Novatel Wireless, Inc. sees Q1 2014 revenue of $50-54 million, versus the consensus of $75 million.

Big Lots, Inc. (NYSE: BIG) 18.9% HIGHER; reported Q4 EPS of $1.45, $0.03 better than the analyst estimate of $1.42. Revenue for the quarter came in at $1.64 billion versus the consensus estimate of $1.62 billion. Comparable store sales for U.S. stores open at least fifteen months decreased 3.0% for the quarter, which is consistent with our previously communicated guidance.

Baxano Surgical, Inc. (Nasdaq: BAXS) 15.4% LOWER; fourth quarter results

Alaska Communications (NASDAQ: ALSK) 13.3% LOWER; reported Q4 EPS of ($0.16), may not compare the analyst estimate of $0.02. Revenue for the quarter came in at $74.5 million versus the consensus estimate of $73.06 million.

Violin Memory (NYSE: VMEM) 12.4% LOWER; reported Q4 EPS of ($0.28), in-line with the analyst estimate of ($0.28). Revenue for the quarter came in at $28 million versus the consensus estimate of $30.77 million.

Analogic Corp (NASDAQ: ALOG) 12% LOWER; reported Q2 EPS of $1.17, $0.03 worse than the analyst estimate of $1.20. Revenue for the quarter came in at $141.1 million versus the consensus estimate of $151.71 million.

dELIA*s, Inc. (NASDAQ: DLIA) 9% HIGHER; Chase Coleman's hedge fund Tiger Global Management disclosed a 6.46%, stake in the company.

NewLink Genetics Corporation (Nasdaq: NLNK) 8.2% LOWER; announced the continuation of the Phase 3 IMPRESS clinical study of algenpantucel-L for patients with surgically resected pancreatic cancer following the first of two planned interim data analyses.

Northwest Biotherapeutics (NASDAQ: NWBO) 8% HIGHER; announced today, in response to shareholder inquiries, that the Data Safety Monitoring Board (DSMB) has made an unblinded review of the safety data for the Company's ongoing international Phase III GBM Trial, and has recommended that the trial continue as planned.

GT Advanced Technologies Inc. (NASDAQ: GTAT) 8% HIGHER; Credit Suisse upgraded GTAT from Neutral to Outperform and raised its price target from $18 to $24

Cross Country Healthcare, Inc. (NASDAQ: CCRN) 7.8% HIGHER; upgraded at Citi and Cantor following Thursday's sell-off

Benefitfocus (NASDAQ: BNFT) 7% LOWER; reported Q4 EPS of ($0.32), $0.02 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $30.3 million versus the consensus estimate of $28.57 million. Benefitfocus sees a Q1 2014 loss of ($0.53)-($0.55), versus the consensus of a ($0.35) loss. Benefitfocus sees Q1 2014 revenue of $29.6-30.1 million, versus the consensus of $29.7 million. Benefitfocus sees FY2014 loss of ($2.41)-($2.57), versus the consensus of a ($1.49) loss. Benefitfocus sees FY2014 revenue of $130-134 million, versus the consensus of $130 million.

Plug Power Inc. (NASDAQ: PLUG) 5.6% HIGHER; CEO will be on CNBC

Foot Locker, Inc. (NYSE: FL) 5% HIGHER; reported Q4 EPS of $0.81, versus the analyst estimate of $0.76. Revenue for the quarter came in at $1.79 billion versus the consensus estimate of $1.76 billion.

CDW (Nasdaq: CDW) 5% LOWER; announced the commencement of a public offering of 10,000,000 shares of its common stock held by the selling stockholders pursuant to a registration statement filed with the Securities and Exchange Commission. The underwriter will have a 30-day option to purchase up to an additional 1,500,000 shares of common stock from the selling stockholders. CDW Corporation will not receive any of the proceeds from the sale of the shares of common stock.

Harvard Apparatus Regenerative Technology (NASDAQ: HART) 4% HIGHER; Q4 results, continued momentum

Emergent Biosolutions (NYSE: EBS) 4.4% HIGHER; reported Q4 EPS of $0.42, $0.06 better than the analyst estimate of $0.36. Revenue for the quarter came in at $94.1 million versus the consensus estimate of $93.83 million. Emergent Biosolutions sees FY2014 revenue of $45-55 million, versus the consensus of $46.8 million.

Comtech Telecommunications (NASDAQ: CMTL) 4.3% HIGHER; reported Q2 EPS of $0.32, $0.06 better than the analyst estimate of $0.26. Revenue for the quarter came in at $85 million versus the consensus estimate of $80.33 million. Comtech Telecommunications sees FY2014 EPS of $1.14-$1.26, versus the consensus of $1.19. Comtech Telecommunications sees FY2014 revenue of $325-345 million, versus the consensus of $336.62 million.

The Fresh Market, Inc. (NASDAQ: TFM) 3.6% HIGHER; reported Q4 EPS of $0.39, $0.03 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $425.8 million versus the consensus estimate of $428.6 million. Comparable store sales increased 3.1% The fourth quarter comparable store sales increase was due to a 1.6% increase in average transaction size and a 1.5% increase in transaction volume. Though winter storms created volatility in transaction volume throughout the quarter, promotional activity drove average transaction size and incremental customer traffic. The Fresh Market, Inc. sees FY2014 EPS of $1.56-$1.66, versus the consensus of $1.67. The Fresh Market, Inc. sees Q1 2014 EPS of $0.41-$0.44, versus the consensus of $0.50.

Jamba, Inc. (NASDAQ: JMBA) 3.2% HIGHER; reported Q4 EPS of ($0.33), $0.05 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $44.1 million versus the consensus estimate of $43.78 million.

21Vianet Group, Inc. (NASDAQ: VNET) 2% LOWER; reported Q4 EPS of ($0.01), may not compare to the analyst estimate of $0.07. Revenue for the quarter came in at $90.2 million versus the consensus estimate of $88.77 million. 21Vianet Group, Inc. sees Q1 2014 revenue of $95-98 million, versus the consensus of $95.68 million.

Gap Inc. (NYSE: GPS) 3.1% LOWER; reported net sales for the four-week period ended March 1, 2014 were $929 million compared with net sales of $966 million for the four-week period ended March 2, 2013. Gap Inc.’s comparable sales for February 2014 were down 7 percent versus a 3 percent increase last year.

GOGO (NASDAQ: GOGO) 3% HIGHER; Steven A. Cohen's hedge fund SAC Capital disclosed a 5.41%, or 4,545,508 share, stake in the company in a new 13G filing. This is up 3,342.26% from the 132,050 shares held at the end of the latest quarter ending December 31, 2013.


Alpha Natural Resources (NYSE: ANR) 2.4% LOWER; Goldman Sachs downgraded from Neutral to Sell with a price target of $4.00 (from $6.00).

xG Technology (NASDAQ: XGTI) 2.7% HIGHER; reported Q4 EPS of ($0.23), versus ($0.78) last year. Revenue for the quarter came in at $373 thousand versus $0 last year. On a pro forma basis, assuming the recognition of $480,000 of deferred revenue in the quarter, total fourth quarter 2013 revenues were $853,000 compared to $0.0 revenue in the fourth quarter of 2012.

Qihoo 360 Technology (NYSE: QIHU) 2.2% HIGHER; reported Q4 EPS of $0.70, $0.27 better than the analyst estimate of $0.43. Revenue for the quarter came in at $221.6 million versus the consensus estimate of $209.73 million. Qihoo 360 Technology sees FY2014 revenue of $226-228 million, versus the consensus of $202.3 million

H&R Block, Inc. (NYSE: HRB) 1.8% LOWER; reported Q3 EPS of ($0.77), $0.66 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $199.8 million, may not compare to the consensus estimate of $519.31 million.

Finisar Corp (NASDAQ: FNSR) 1.5% HIGHER; reported Q3 EPS of $0.44, in-line with the analyst estimate of $0.44. Revenue for the quarter came in at $294.02 million versus the consensus estimate of $299.1 million. Finisar Corp sees Q4 2014 EPS of $0.38-$0.42, versus the consensus of $0.4. Finisar Corp sees Q4 2014 revenue of $290-305 million, versus the consensus of $297.18 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

SAC Capital, Credit Suisse, Steven A. Cohen, Citi, D.A. Davidson, Tiger Global Management, Hedge Funds, 13G

Add Your Comment